Teladoc Net Interest Income vs Cost Of Revenue Analysis

TDOC Stock

USD 10.62 0.22 2.12%

Teladoc financial indicator trend analysis is much more than just breaking down Teladoc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Teladoc is a good investment. Please check the relationship between Teladoc Net Interest Income and its Cost Of Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.

Net Interest Income vs Cost Of Revenue

Net Interest Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Teladoc Net Interest Income account and Cost Of Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Teladoc's Net Interest Income and Cost Of Revenue is -0.04. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Teladoc, assuming nothing else is changed. The correlation between historical values of Teladoc's Net Interest Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Teladoc are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Net Interest Income i.e., Teladoc's Net Interest Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Cost Of Revenue

Cost of Revenue is found on Teladoc income statement and represents the costs associated with goods and services Teladoc provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Teladoc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.At present, Teladoc's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 27.02, whereas Selling General Administrative is forecasted to decline to about 236 M.

	2021	2022	2023	2024 (projected)
Interest Expense	80.4M	9.3M	22.3M	25.1M
Depreciation And Amortization	219.6M	270.6M	351.3M	368.9M

Interest Expense Depreciation And Amortization

Teladoc fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.69	0.55	0.66	0.99	0.89	0.8	0.73	-0.14	0.77	0.62	1.0	0.3	0.23	0.68	0.63	0.63	0.98	-0.35	0.63	0.7	0.66	0.75	0.69	0.56	0.64
Short Long Term Debt Total	0.69		0.97	0.99	0.62	0.86	0.92	0.93	-0.8	0.99	0.97	0.65	0.86	0.83	1.0	0.97	0.99	0.53	-0.48	0.89	1.0	0.98	0.98	1.0	0.95	0.99
Other Current Liab	0.55	0.97		0.98	0.47	0.75	0.87	0.9	-0.89	0.95	0.95	0.5	0.89	0.9	0.97	0.94	0.98	0.37	-0.42	0.88	0.97	0.99	0.95	0.97	0.91	0.96
Total Current Liabilities	0.66	0.99	0.98		0.59	0.82	0.9	0.92	-0.83	0.98	0.97	0.62	0.89	0.87	0.99	0.97	1.0	0.49	-0.45	0.89	0.99	0.99	0.99	1.0	0.96	0.98
Total Stockholder Equity	0.99	0.62	0.47	0.59		0.85	0.74	0.67	-0.05	0.71	0.55	1.0	0.22	0.15	0.61	0.56	0.56	0.99	-0.31	0.55	0.63	0.59	0.69	0.63	0.49	0.57
Other Liab	0.89	0.86	0.75	0.82	0.85		0.94	0.84	-0.41	0.88	0.81	0.87	0.51	0.45	0.85	0.83	0.81	0.81	-0.53	0.81	0.87	0.81	0.85	0.86	0.73	0.83
Property Plant And Equipment Net	0.8	0.92	0.87	0.9	0.74	0.94		0.87	-0.6	0.94	0.88	0.76	0.66	0.64	0.92	0.88	0.89	0.68	-0.5	0.93	0.92	0.91	0.92	0.92	0.81	0.9
Net Debt	0.73	0.93	0.9	0.92	0.67	0.84	0.87		-0.69	0.94	0.82	0.69	0.73	0.68	0.92	0.82	0.9	0.59	-0.38	0.79	0.93	0.95	0.94	0.93	0.81	0.85
Retained Earnings	-0.14	-0.8	-0.89	-0.83	-0.05	-0.41	-0.6	-0.69		-0.73	-0.8	-0.08	-0.95	-0.98	-0.8	-0.79	-0.85	0.06	0.29	-0.72	-0.79	-0.83	-0.76	-0.8	-0.84	-0.81
Accounts Payable	0.77	0.99	0.95	0.98	0.71	0.88	0.94	0.94	-0.73		0.95	0.73	0.8	0.78	0.99	0.95	0.98	0.63	-0.46	0.9	0.99	0.98	1.0	0.99	0.91	0.96
Cash	0.62	0.97	0.95	0.97	0.55	0.81	0.88	0.82	-0.8	0.95		0.57	0.88	0.86	0.97	1.0	0.98	0.45	-0.5	0.89	0.97	0.94	0.94	0.97	0.96	1.0
Non Current Assets Total	1.0	0.65	0.5	0.62	1.0	0.87	0.76	0.69	-0.08	0.73	0.57		0.25	0.18	0.64	0.58	0.59	0.99	-0.32	0.57	0.66	0.62	0.71	0.65	0.51	0.6
Non Currrent Assets Other	0.3	0.86	0.89	0.89	0.22	0.51	0.66	0.73	-0.95	0.8	0.88	0.25		0.97	0.87	0.87	0.91	0.1	-0.33	0.73	0.85	0.86	0.84	0.86	0.95	0.88
Other Assets	0.23	0.83	0.9	0.87	0.15	0.45	0.64	0.68	-0.98	0.78	0.86	0.18	0.97		0.83	0.85	0.88	0.03	-0.32	0.77	0.82	0.85	0.81	0.83	0.89	0.86
Long Term Debt	0.68	1.0	0.97	0.99	0.61	0.85	0.92	0.92	-0.8	0.99	0.97	0.64	0.87	0.83		0.98	0.99	0.52	-0.48	0.89	1.0	0.98	0.98	1.0	0.95	0.99
Cash And Short Term Investments	0.63	0.97	0.94	0.97	0.56	0.83	0.88	0.82	-0.79	0.95	1.0	0.58	0.87	0.85	0.98		0.98	0.46	-0.54	0.88	0.98	0.93	0.94	0.98	0.96	1.0
Net Receivables	0.63	0.99	0.98	1.0	0.56	0.81	0.89	0.9	-0.85	0.98	0.98	0.59	0.91	0.88	0.99	0.98		0.46	-0.47	0.89	0.99	0.98	0.98	0.99	0.97	0.99
Good Will	0.98	0.53	0.37	0.49	0.99	0.81	0.68	0.59	0.06	0.63	0.45	0.99	0.1	0.03	0.52	0.46	0.46		-0.27	0.48	0.54	0.49	0.6	0.53	0.38	0.47
Common Stock Total Equity	-0.35	-0.48	-0.42	-0.45	-0.31	-0.53	-0.5	-0.38	0.29	-0.46	-0.5	-0.32	-0.33	-0.32	-0.48	-0.54	-0.47	-0.27		-0.48	-0.48	-0.42	-0.42	-0.48	-0.43	-0.52
Common Stock Shares Outstanding	0.63	0.89	0.88	0.89	0.55	0.81	0.93	0.79	-0.72	0.9	0.89	0.57	0.73	0.77	0.89	0.88	0.89	0.48	-0.48		0.89	0.89	0.88	0.89	0.8	0.9
Non Current Liabilities Total	0.7	1.0	0.97	0.99	0.63	0.87	0.92	0.93	-0.79	0.99	0.97	0.66	0.85	0.82	1.0	0.98	0.99	0.54	-0.48	0.89		0.98	0.98	1.0	0.94	0.99
Other Current Assets	0.66	0.98	0.99	0.99	0.59	0.81	0.91	0.95	-0.83	0.98	0.94	0.62	0.86	0.85	0.98	0.93	0.98	0.49	-0.42	0.89	0.98		0.99	0.99	0.91	0.96
Other Stockholder Equity	0.75	0.98	0.95	0.99	0.69	0.85	0.92	0.94	-0.76	1.0	0.94	0.71	0.84	0.81	0.98	0.94	0.98	0.6	-0.42	0.88	0.98	0.99		0.99	0.93	0.96
Total Liab	0.69	1.0	0.97	1.0	0.63	0.86	0.92	0.93	-0.8	0.99	0.97	0.65	0.86	0.83	1.0	0.98	0.99	0.53	-0.48	0.89	1.0	0.99	0.99		0.95	0.99
Property Plant And Equipment Gross	0.56	0.95	0.91	0.96	0.49	0.73	0.81	0.81	-0.84	0.91	0.96	0.51	0.95	0.89	0.95	0.96	0.97	0.38	-0.43	0.8	0.94	0.91	0.93	0.95		0.96
Total Current Assets	0.64	0.99	0.96	0.98	0.57	0.83	0.9	0.85	-0.81	0.96	1.0	0.6	0.88	0.86	0.99	1.0	0.99	0.47	-0.52	0.9	0.99	0.96	0.96	0.99	0.96

Click cells to compare fundamentals

Teladoc Account Relationship Matchups

Teladoc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.6B	17.8B	17.7B	4.3B	4.4B	4.9B
Short Long Term Debt Total	465.4M	1.5B	1.3B	1.6B	1.6B	1.7B
Other Current Liab	63.6M	178.6M	169.1M	324.5M	257.0M	269.9M
Total Current Liabilities	90.2M	332.6M	331.0M	399.8M	420.6M	441.6M
Total Stockholder Equity	1.0B	15.9B	16.0B	2.3B	2.3B	4.0B
Other Liab	33.2M	106.2M	81.1M	56.4M	64.9M	38.6M
Property Plant And Equipment Net	36.7M	75.2M	74.0M	71.5M	72.1M	36.4M
Net Debt	(48.9M)	732.0M	374.0M	655.1M	468.6M	492.0M
Retained Earnings	(507.5M)	(992.7M)	(1.4B)	(15.0B)	(15.2B)	(14.5B)
Accounts Payable	9.1M	46.0M	47.3M	47.7M	43.6M	45.8M
Cash	514.4M	733.3M	893.5M	918.2M	1.1B	1.2B
Non Current Assets Total	1.0B	16.7B	16.5B	3.0B	2.9B	4.2B
Non Currrent Assets Other	6.5M	18.4M	20.7M	48.5M	80.3M	84.3M
Other Assets	6.5M	2.1K	20.7M	48.5M	55.8M	58.6M
Long Term Debt	440.4M	1.4B	1.2B	1.5B	1.5B	1.6B
Cash And Short Term Investments	517.1M	786.6M	896.0M	918.2M	1.1B	1.2B
Net Receivables	56.9M	169.3M	169.0M	210.6M	230.1M	241.6M
Good Will	746.1M	14.6B	14.5B	1.1B	1.2B	1.2B
Common Stock Total Equity	73K	150K	160K	163K	146.7K	291.3K
Common Stock Shares Outstanding	71.8M	90.5M	156.9M	161.5M	164.6M	88.4M
Liabilities And Stockholders Equity	1.6B	17.8B	17.7B	4.3B	4.4B	4.9B
Non Current Liabilities Total	498.6M	1.5B	1.4B	1.6B	1.6B	1.7B
Other Current Assets	14.0M	94.5M	87.4M	130.3M	105.8M	111.1M
Other Stockholder Equity	1.5B	16.9B	17.5B	17.4B	17.6B	18.5B
Total Liab	588.8M	1.9B	1.7B	2.0B	2.1B	2.2B
Property Plant And Equipment Gross	36.7M	75.2M	74.0M	71.5M	131.8M	138.4M
Total Current Assets	588.0M	1.1B	1.2B	1.3B	1.5B	1.6B
Accumulated Other Comprehensive Income	(17.2M)	18.5M	(6.3M)	(42.8M)	(37.0M)	(35.1M)
Intangible Assets	225.5M	2.0B	1.9B	1.8B	1.7B	1.8B
Common Stock	73K	150K	160K	163K	167K	276.9K
Property Plant Equipment	10.3M	28.6M	74.0M	29.6M	34.1M	19.4M
Net Tangible Assets	67.5M	(665.2M)	(368.7M)	(556.1M)	(500.5M)	(475.5M)
Current Deferred Revenue	12.5M	52.4M	75.6M	90.5M	95.7M	100.4M
Short Term Investments	79.5M	54.5M	2.7M	53.2M	2.5M	0.0
Deferred Long Term Liab	21.7M	104.6M	2.4M	54.8M	63.0M	66.2M
Short Term Debt	5.1M	54.0M	26M	13.6M	10.8M	15.8M
Retained Earnings Total Equity	(507.5M)	(992.7M)	(1.4B)	(15.0B)	(13.5B)	(12.8B)
Long Term Debt Total	440.4M	1.4B	1.2B	1.5B	1.8B	1.9B
Capital Surpluse	1.5B	16.9B	17.5B	17.4B	20.0B	21.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:

How To Invest In Teladoc

Details

Is Teladoc Stock a good investment?

Details

What is Teladoc's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.

You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.78)

Revenue Per Share

15.333

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.03)

Return On Equity

(0.52)

The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Teladoc Net Interest Income vs Cost Of Revenue Analysis

Net Interest Income vs Cost Of Revenue

Net Interest Income vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Net Interest Income

Cost Of Revenue

Teladoc fundamental ratios Correlations

Teladoc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Teladoc fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Net Receivables	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Total Current Liabilities

Other Assets	- 0.98	Retained Earnings
Non Currrent Assets Other	- 0.95	Retained Earnings
Retained Earnings	- 0.89	Other Current Liab
Net Receivables	- 0.85	Retained Earnings
Property Plant And Equipment Gross	- 0.84	Retained Earnings
Other Current Assets	- 0.83	Retained Earnings